US › Healthcare

Femasys Inc (FEMY)

US · Healthcare · Medical Instruments & Supplies

$3.05+2.69%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$424,889
Revenue YoY
+24.5%
Net profit
$328,646
Profit YoY
+105.6%
EPS
$-1.46
EPS estimate
$-1.80
Net margin
77.3%

EPS came in at -1.46 against a street estimate of -1.80 — a beat of 18.9%.

Key statistics

Market cap
$8.4M
Forward P/E
0.0
P/B
1.20
Book value
$2.41
EPS (TTM)
$-4.63
52-week high
$22.20
52-week low
$2.64
50-day MA
$4.86
200-day MA
$10.32
Beta
-2.13

Analyst view

Analysts rate Femasys Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $63.33.

Shareholding

Insiders
9.40%
Institutions
9.90%

Largest institutional holders

FundStake
Dauntless Investment Group, LLC9.99%
Vanguard Group Inc2.34%
Vanguard Capital Management, LLC2.05%
Geode Capital Management, LLC1.03%
Vanguard Fiduciary Trust Co0.41%
BlackRock Inc0.30%
Northern Trust Corp0.20%
Clear Creek Investment Mgmt LLC0.19%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Femasys Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.